3.190EUR+3.91%Mkt Cap: 65.25M $P/E: —Today
MaaT Pharma SA, a late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival. Its products pipeline includes MaaT013, that is in p…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap65.25M $
Enterprise Value55.83M $
Revenue (TTM)4.92M $
Gross Profit3.40M $
Net Income (TTM)-33.76M $
Revenue/Share0.3087 USD
Last Price3.190 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees52
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0012634822
Valuation
P/E (Trailing)—
P/E (Forward)-2.80
PEG—
EV/EBITDA-1.75
EV/Revenue11.35
P/S12.98
P/B32.50
EPS (TTM)-1.90
EPS (Forward)-1.11
52W Range
2.32014% of range8.620
52W High8.620 EUR
52W Low2.320 EUR
Profitability
Gross Margin69.05%
Oper. Margin-714.35%
EBITDA Margin0.00%
Profit Margin-686.58%
ROE-1726.57%
ROA-69.72%
Growth
Revenue Growth40.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.08M $
CapEx (TTM)660.87K $
FCF Margin-313.01%
FCF Yield-23.59%
Net Debt-8.07M $
Net Debt/EBITDA0.25
Balance Sheet
Debt/Equity8.56
Current Ratio1.94
Quick Ratio1.87
Book Value/Sh0.0960 EUR
Cash/Share1.320 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.500 EUR
Upside (mean)+103.8%
Target Range3.000 EUR – 10.00 EUR
€3.000+103.8% to mean€10.00
# Analysts2
Ownership
Shares Out.18.82M
Float11.04M
Insiders22.06%
Institutions46.64%
Technical
SMA 502.773 (+15.0%)
SMA 2004.822 (-33.8%)
Beta0.40
S&P 52W Chg18.16%
Avg Vol (30d)33.14K
Avg Vol (10d)41.14K
Technical Indicators
RSI (14)58.5
MACD0.0540
MACD Signal0.0146
MACD Hist.+0.0393
BB Upper3.102 EUR
BB Middle2.868 EUR
BB Lower2.633 EUR
BB Width16.37%
ATR (14)0.1543 EUR
Vol Ratio (20d)2.60x